Josefina Casas Selected Research

perfluorohexanoic acid

6/2014

Perfluorinated chemicals: differential toxicity, inhibition of aromatase activity and alteration of cellular lipids in human placental cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Josefina Casas Research Topics

Disease

26	Neoplasms (Cancer) 06/2022 - 04/2007
9	Inflammation (Inflammations) 01/2018 - 05/2013
7	Infections 01/2019 - 07/2010
6	Gaucher Disease (Gaucher's Disease) 05/2017 - 07/2007
4	Alzheimer Disease (Alzheimer's Disease) 10/2021 - 02/2018
4	Melanoma (Melanoma, Malignant) 11/2020 - 01/2011
4	Obesity 01/2020 - 08/2014
4	Glioma (Gliomas) 11/2016 - 01/2011
3	Body Weight (Weight, Body) 01/2020 - 01/2018
3	Flavivirus Infections 01/2019 - 01/2016
3	Cystic Fibrosis (Mucoviscidosis) 08/2017 - 08/2013
3	Choriocarcinoma 01/2015 - 06/2014
2	Breast Neoplasms (Breast Cancer) 01/2022 - 06/2012
2	Amyloid Plaque 10/2021 - 01/2019
2	Type C Niemann-Pick Disease (Niemann Pick Disease, Type C) 01/2021 - 11/2020
2	Fatty Liver 01/2020 - 12/2015
2	Glucose Intolerance 01/2020 - 01/2018
2	Non-alcoholic Fatty Liver Disease 01/2020 - 12/2015
2	Hypertension (High Blood Pressure) 01/2020 - 01/2018
2	Hypoxia (Hypoxemia) 06/2019 - 01/2018
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 04/2014
2	Amyloidosis 01/2019 - 02/2018
2	Pancreatitis 01/2018 - 05/2013
2	Insulin Resistance 01/2018 - 01/2018
2	Pneumonia (Pneumonitis) 08/2017 - 06/2016
2	Chronic Obstructive Pulmonary Disease (COPD) 08/2017 - 06/2016
2	Retinitis Pigmentosa (Pigmentary Retinopathy) 07/2017 - 05/2013
2	Stomach Neoplasms (Stomach Cancer) 01/2017 - 09/2009
2	Carcinogenesis 05/2016 - 05/2013
2	West Nile Fever 01/2016 - 10/2014
2	Farber Lipogranulomatosis 08/2014 - 06/2013
2	Prostatic Neoplasms (Prostate Cancer) 05/2013 - 07/2011
2	Carcinoma (Carcinomatosis) 12/2012 - 10/2011
1	Adenocarcinoma of Lung 06/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	Fabry Disease (Fabry's Disease) 01/2021
1	Fatigue 01/2021
1	Nevus (Nevi) 11/2020

Drug/Important Bio-Agent (IBA)

18	SphingolipidsIBA 06/2022 - 11/2011
17	CeramidesIBA 01/2021 - 07/2011
15	LipidsIBA 01/2022 - 01/2011
15	EnzymesIBA 01/2021 - 07/2007
8	Acid CeramidaseIBA 01/2021 - 04/2007
5	dihydroceramideIBA 01/2021 - 09/2009
4	Fatty Acids (Saturated Fatty Acids)IBA 10/2021 - 05/2013
4	CeramidasesIBA 04/2021 - 08/2011
4	Pharmaceutical PreparationsIBA 01/2021 - 06/2012
4	dihydroceramide desaturaseIBA 02/2018 - 07/2010
4	Glucosylceramidase (Glucocerebrosidase)IBA 05/2017 - 07/2007
3	Amyloid (Amyloid Fibrils)IBA 10/2021 - 02/2018
3	AcidsIBA 04/2021 - 01/2016
3	CholesterolIBA 01/2021 - 12/2015
3	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 11/2020 - 08/2014
3	SphingomyelinsIBA 11/2020 - 08/2014
3	Biomarkers (Surrogate Marker)IBA 10/2020 - 01/2018
3	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2018
3	DiglyceridesIBA 01/2020 - 01/2018
3	Dinoprostone (PGE2)FDA Link 01/2018 - 08/2013
3	thermozymocidin (myriocin)IBA 08/2017 - 01/2014
3	GlycosidesIBA 09/2015 - 01/2011
3	Glucosylceramides (Glucocerebrosides)IBA 01/2014 - 03/2009
2	pachastrissamineIBA 06/2022 - 01/2017
2	Phosphotransferases (Kinase)IBA 01/2022 - 01/2021
2	Peptides (Polypeptides)IBA 10/2021 - 01/2019
2	AMP-Activated Protein KinasesIBA 01/2021 - 01/2018
2	Acetyl-CoA CarboxylaseIBA 01/2021 - 01/2019
2	Dronabinol (THC)FDA LinkGeneric 01/2021 - 11/2016
2	GalactosylceramidaseIBA 11/2020 - 04/2014
2	EndocannabinoidsIBA 11/2020 - 01/2019
2	FructoseIBA 01/2020 - 01/2018
2	Carnitine O-Palmitoyltransferase (Carnitine Palmitoyltransferase II)IBA 01/2020 - 01/2014
2	fagomineIBA 01/2020 - 01/2018
2	LeptinIBA 01/2020 - 01/2018
2	Uric Acid (Urate)IBA 01/2020 - 01/2018
2	Hormones (Hormone)IBA 01/2019 - 07/2011
2	Oleic Acid (Oleate)IBA 01/2018 - 05/2013
2	AntioxidantsIBA 01/2018 - 01/2015
2	Interleukin-6 (Interleukin 6)IBA 01/2018 - 01/2016
2	SphingosineIBA 05/2016 - 06/2012
2	Nonesterified Fatty Acids (NEFA)IBA 12/2015 - 05/2013
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2013 - 05/2013
2	(2R,3Z)- N- (1- hydroxyoctadec- 3- en- 2- yl)pivalamideIBA 06/2012 - 07/2011
2	Antineoplastic Agents (Antineoplastics)IBA 05/2012 - 07/2011
2	Antimitotic AgentsIBA 10/2011 - 01/2011
1	flotillinsIBA 01/2022
1	sphingosine kinaseIBA 01/2022
1	Alkaline CeramidaseIBA 04/2021
1	Activating Transcription Factor 4IBA 01/2021
1	acylcarnitineIBA 01/2021
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2021
1	Prokaryotic Initiation Factor-2IBA 01/2021
1	ABTL0812IBA 01/2021
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2021
1	Sirolimus (Rapamycin)FDA Link 01/2021
1	X-Box Binding Protein 1IBA 01/2021
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2021
1	Microphthalmia-Associated Transcription FactorIBA 11/2020

Therapy/Procedure

7	Therapeutics 11/2020 - 05/2012
6	Drug Therapy (Chemotherapy) 01/2018 - 04/2007